Attached files
file | filename |
---|---|
EX-99.1 - Calumet Specialty Products Partners, L.P. | v211625_ex99-1.htm |
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 16, 2011
CALUMET SPECIALTY PRODUCTS PARTNERS,
L.P.
(Exact
name of registrant as specified in its charter)
DELAWARE
(State
or other jurisdiction
of
incorporation)
|
000-51734
(Commission
File Number)
|
37-1516132
(IRS
Employer
Identification
No.)
|
2780
Waterfront Pkwy E. Drive
Suite 200
Indianapolis,
Indiana 46214
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code (317) 328-5660
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02 Results of Operations
and Financial Condition.
On
February 16, 2011, Calumet Specialty Products Partners, L.P. reported results of
operations for the quarter ended December 31, 2010 pursuant to a press release.
A copy of the press release is furnished as Exhibit 99.1 to this Current
Report on Form 8-K.
In
accordance with General Instruction B.2 of Form 8-K, the information contained
in this report shall not be deemed “filed” for the purpose of Section 18 of
the Securities Exchange Act of 1934 or otherwise subject to the liabilities of
that section, nor shall such information and Exhibit be deemed incorporated by
reference into any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as shall be expressly set forth by specific
reference in such filing.
(c) Exhibits.
Exhibit
Number
|
Description
|
|
Exhibit 99.1
|
Press
Release dated February 16, 2011.
|
2
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
CALUMET
SPECIALTY PRODUCTS
|
||||
PARTNERS,
L.P.
|
||||
By:
|
CALUMET
GP, LLC,
its
General Partner
|
By:
|
/s/
R. Patrick Murray, II
|
|||
Name: R.
Patrick Murray, II
|
||||
Title: Vice
President, Chief Financial Officer and Secretary
|
||||
February
16, 2011
|
3
Exhibit
Number
|
Description
|
|
Exhibit 99.1
|
Press
Release dated February 16, 2011.
|
4